Close
Enter your
text here

birth control

Weighing the Risk of Blood Clots With Reward of Less Pain
 Weighing the Risk of Blood Clots With Reward of Less Pain 1024 683 Pam Georgiana
By: Pam Georgiana

For people with sickle cell disease who menstruate, hormonal contraception can be effective against SCD-related pain, but it also raises the risk of thrombosis.   As people with sickle cell disease (SCD) transition into their reproductive years, health care providers are increasingly focused on optimizing their overall health, including the safe management of contraception. For…

What Pediatricians Need to Know About Over-the-Counter Oral Contraception
 What Pediatricians Need to Know About Over-the-Counter Oral Contraception 1024 683 Elise Berlan, MD, MPH and Caroline Weingart, MD
By: Elise Berlan, MD, MPH and Caroline Weingart, MD

The first over-the-counter contraceptive pill – the Opill® – is currently available in retail outlets and online. The FDA approved the sale of Opill® (nongestural 0.075mg), the first over-the-counter birth control pill without age restrictions, in July 2023. Now, nearly a year later, it will be available soon in retail outlets and online. As a…

User Experiences with Subcutaneous DMPA
 User Experiences with Subcutaneous DMPA 1024 683 Mary Bates, PhD
By: Mary Bates, PhD

Survey reveals high satisfaction among adolescents and young adults using subcutaneous DMPA. Depot medroxyprogesterone acetate (DMPA) is a progestin-only injectable contraceptive that is used as a birth control method and in the treatment of heavy or painful menstrual periods, endometriosis, and for menstrual suppression. DMPA can be injected intramuscularly or subcutaneously, with no difference in…